Going with the flow: from circulating tumor cells to DNA.

Bidard, Francois-Clement; Weigelt, Britta; Reis-Filho, Jorge S · Sci Transl Med · 2013

Level V

Where this comes from

Abstract

Molecular analyses of circulating tumor DNA (ctDNA) in plasma from cancer patients have the potential to deliver minimally invasive diagnostic and disease-monitoring biomarkers. Drawing from experience gained through the translation of circulating tumor cell detection to clinical tests, we discuss ctDNA as a source of tumor material for biomarker development.

Medical subject headings